Related Experiment Videos
Gene Therapy of Bladder Cancer
1Department of Urology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.
Abstract:
BACKGROUND: The incidence of bladder cancer has been steadily increasing and, despite improvements in treatment, many patients will not survive five years. Gene therapy is a promising approach that may improve the management of this disease. METHODS: Gene therapy involves two steps: (1) selection of an appropriate gene and (2) transfer of that gene to the target cells. RESULTS: Five broad categories of cancer gene therapy are undergoing clinical evaluation: (1) immunological augmentation by cytokine or (2) foreign gene transfer into tumor cells, (3) insertion of a suicide gene into tumor cells, (4) tumor suppressor gene reconstitution, and (5) bone marrow protection by insertion of a multidrug resistance gene. CONCLUSIONS: Although many gene transfer approaches have great intuitive appeal, several constraints, including problems with methods of gene transfer, must be overcome before this biologic approach can reach its potential.
Insights
Gene therapy offers a promising new avenue for treating bladder cancer, a disease with a rising incidence and poor survival rates. Current research explores various gene transfer methods to improve patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Bladder cancer incidence is increasing, with many patients facing poor prognoses despite treatment advancements.
- Gene therapy presents a potential strategy to enhance bladder cancer management.
Purpose of the Study:
- To review the current landscape and potential of gene therapy for bladder cancer treatment.
- To outline the fundamental steps and diverse approaches in cancer gene therapy.
Main Methods:
- Gene therapy involves selecting a suitable gene and transferring it to target cells.
- Clinical evaluation of five categories of cancer gene therapy approaches.
Main Results:
- Five categories of gene therapy are under clinical investigation: immunological augmentation, foreign gene transfer, suicide gene therapy, tumor suppressor gene therapy, and multidrug resistance gene therapy.
- These methods aim to enhance anti-tumor immunity, directly kill cancer cells, restore tumor suppression, or protect normal cells.
Conclusions:
- While gene therapy holds significant promise for bladder cancer, challenges in gene transfer methods need resolution.
- Overcoming technical constraints is crucial for realizing the full potential of gene therapy in clinical practice.